politics

Moderna and Partners Awarded $60 Million for Ebola Vaccine Development

1 Haziran 2026Japan Times

Moderna and several other organizations have received $60 million in funding to expedite the development of an Ebola vaccine. Richard Hatchett, the head of the Coalition for Epidemic Preparedness Innovations (CEPI), announced that vaccines for the Ebola Bundibugyo virus could be ready for trials within a few months.
This funding aims to enhance global preparedness against potential Ebola outbreaks.
Ebola has been a significant public health threat in various regions, particularly in Africa. The Bundibugyo strain has been less common but still poses a risk.
The swift mobilization of resources for the Ebola vaccine development highlights the increasing urgency and importance of pandemic preparedness. With past outbreaks demonstrating the devastating impact of Ebola, the rapid timeline proposed by CEPI could significantly mitigate future risks.

NewsAI özeti

This article is for informational purposes only and does not constitute medical advice.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.